Nutrition and Exercise Program for Elderly Colorectal Cancer Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Mobile Health Management Frailty Care Program.
- Who it may be relevant to
- Registry conditions: Colorectal Cancer. Basic parameters: from 60 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Taiwan
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effects of the Tailored Frailty Prevention Program With Exercise and Nutrition Management to Improve Physical Performance and Health Status in Older Patients With Colorectal Cancer
Overview
The goal of this interventional study is to evaluate the effect of mobile health intervention on frailty, physical fitness, physical activity, and nutritional status of elderly patients with colorectal cancer. The main questions it aim to answer are: 1. Does the mobile health intervention reduce frailty in elderly colorectal cancer patients compared to standard care? 2. Does the mobile health intervention improve physical fitness, physical activity, and nutritional status in elderly colorectal cancer patients compared to standard care? Participants will receive the Mobile Health Management Frailty Care Program.
Interventions
- Behavioral Mobile Health Management Frailty Care Program
Through the "LINE" communication software, participants are provided with exercise and nutrition information three times a week, with a total of 36 messages. As well as 6 podcasts of health information and 6 sports videos in total. At weeks 2, 4, and 6, researchers scheduled 5- to 10-minute telephone consultations. Participants can receive guidance through telephone consultations and carry a Xiaomi sports band wearable device to monitor their exercise.
Primary outcome measures
- Frailty [Time frame: Pre-test, sixth week after intervention, 13th week after intervention]
- Physical Activity [Time frame: Pre-test, sixth week after intervention, 13th week after intervention]
- Nutritional Status [Time frame: Pre-test, sixth week after intervention, 13th week after intervention]
Secondary outcome measures (5)
- health-related quality of life [Time frame: Pre-test, sixth week after intervention, 13th week after intervention]
- Depression [Time frame: Pre-test, sixth week after intervention, 13th week after intervention]
- body mass index [Time frame: Pre-test, sixth week after intervention, 13th week after intervention]
- hand grip strength [Time frame: Pre-test, sixth week after intervention, 13th week after intervention]
- walking speed [Time frame: Pre-test, sixth week after intervention, 13th week after intervention]
Eligibility criteria
Inclusion criteria
- Patients diagnosed with colorectal cancer confirmed by a physician.
- Aged 60 and above.
- Have communication skills, able to read and write or converse in Mandarin and Taiwanese.
- Clear consciousness and no mental or cognitive impairment.
- Physical activities are accessible.
- Those who have a smartphone and have experience using smartphones.
Exclusion criteria
- People who have difficulty walking or standing.
- The wrist is not suitable for those wearing sports bracelets.
- People in infectious or protective isolation.
- Those who live alone or in institutions.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Health services research
Study locations
Taiwan · 1 center
- Chang Gung Memorial Hospital — Chiayi City
Identifiers
NCT: NCT06502275 · 202300957B0C601